LP
PFE icon

Longview Partners’s Pfizer PFE Stock Holding History

Longview Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,993,825
Closed -$372M – 26
2018
Q4 		$372M Sell
8,993,825
-17,374,076
-66% -$721M 1.98% 22
2018
Q3 		$1.1B Sell
26,367,901
-529,530
-2% -$20.4M 5.44% 4
2018
Q2 		$926M Sell
26,897,431
-290,502
-1% -$9.93M 4.82% 12
2018
Q1 		$915M Sell
27,187,933
-62,554
-0.2% -$2.15M 4.8% 11
2017
Q4 		$936M Buy
27,250,487
+1,564,853
+6% +$53.4M 4.9% 12
2017
Q3 		$870M Buy
25,685,634
+6,219,759
+32% +$200M 4.7% 15
2017
Q2 		$620M Buy
19,465,875
+1,253,268
+7% +$39.5M 3.58% 19
2017
Q1 		$591M Sell
18,212,607
-771,001
-4% -$24.3M 3.84% 18
2016
Q4 		$585M Sell
18,983,608
-153,673
-0.8% -$4.69M 3.87% 19
2016
Q3 		$615M Sell
19,137,281
-1,138,612
-6% -$38.1M 3.98% 19
2016
Q2 		$677M Sell
20,275,893
-486,315
-2% -$15.5M 4.51% 11
2016
Q1 		$584M Sell
20,762,208
-439,418
-2% -$12.6M 3.88% 20
2015
Q4 		$649M Buy
21,201,626
+232,179
+1% +$7.3M 4.43% 12
2015
Q3 		$625M Sell
20,969,447
-434,689
-2% -$13.9M 4.42% 14
2015
Q2 		$681M Sell
21,404,136
-311,941
-1% -$10.2M 4.47% 15
2015
Q1 		$717M Sell
21,716,077
-140,651
-0.6% -$4.47M 4.97% 13
2014
Q4 		$646M Sell
21,856,728
-182,674
-0.8% -$5.24M 4.76% 13
2014
Q3 		$618M Sell
22,039,402
-238,408
-1% -$6.69M 4.92% 15
2014
Q2 		$627M Buy
22,277,810
+203,875
+0.9% +$5.81M 4.96% 16
2014
Q1 		$673M Sell
22,073,935
-195,401
-0.9% -$5.83M 5.23% 14
2013
Q4 		$647M Buy
22,269,336
+2,847,666
+15% +$82.9M 5.37% 14
2013
Q3 		$529M Buy
19,421,670
+1,842,413
+10% +$50.1M 4.92% 10
2013
Q2 		$467M Buy
+17,579,257
New +$486M 4.64% 12

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Longview Partners's PFE Position: Q1 2019 in Review

Longview Partners sold out of Pfizer (PFE) in Q1 2019, closing a stake of 8,993,825 shares — an estimated $372M sold.

Longview Partners first reported a position in PFE in Q2 2013 and held it in 23 quarters. The position peaked at $1.1B in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Longview Partners reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Longview Partners sold 8,993,825 Pfizer shares in Q1 2019, an estimated $372M.
  • Longview Partners first reported a position in Pfizer in Q2 2013 and held it in 23 quarters.
  • Longview Partners's Pfizer position peaked at $1.1B in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Longview Partners's 13F filing for Q1 2019, filed 15 May 2019.